Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-13-005273
Filing Date
2013-02-07
Accepted
2013-02-07 17:18:15
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 CAMBREX CORP 10-K 12-31-2012 form10k.htm 10-K 2212965
2 EXHIBIT 10.5 ex10_5.htm EX-10.5 102873
3 EXHIBIT 21 ex21.htm EX-21 6711
4 EXHIBIT 23 ex23.htm EX-23 3350
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 20564
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 18846
7 EXHIBIT 32 ex32.htm EX-32 8635
14 graph.jpg GRAPHIC 33419
  Complete submission text file 0001140361-13-005273.txt   13476215

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cbm-20121231.xml EX-101.INS 2176493
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbm-20121231.xsd EX-101.SCH 60139
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbm-20121231_cal.xml EX-101.CAL 112701
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbm-20121231_def.xml EX-101.DEF 282177
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbm-20121231_lab.xml EX-101.LAB 1049338
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbm-20121231_pre.xml EX-101.PRE 577289
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

EIN.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10638 | Film No.: 13583337
SIC: 2834 Pharmaceutical Preparations